Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hematological Malignancies
100%
Immunosuppressive Mechanisms
100%
Programmed Death-ligand 1 (PD-L1)
100%
Regulatory Immune Cells
60%
T Cells
40%
Immune Escape
40%
Cell Signaling Pathways
40%
Immune Response
20%
Clinical Effect
20%
Tumor
20%
Well-defined
20%
Healthy Tissue
20%
Autoimmune
20%
Monoclonal Antibody
20%
Adaptive Immune Response
20%
Therapeutic Targeting
20%
Cytotoxic T Cell Response
20%
Leukemic Cells
20%
Metabolic Enzymes
20%
T Cell Response
20%
Immune Tolerance
20%
Evade
20%
Antileukemic Activity
20%
Solid Tumors
20%
Indoleamine 2,3-dioxygenase 1 (IDO1)
20%
Tolerance Mechanisms
20%
Feedback Mechanism
20%
Tumor Immunity
20%
Anticancer Vaccination
20%
Tryptophan Depletion
20%
Anticancer Immunotherapy
20%
Immunosuppressive Cells
20%
Immunosuppressive Pathways
20%
Tumor Immune Evasion
20%
3-dioxygenase Inhibitor
20%
Anti-leukemia
20%
Immunology and Microbiology
Immunosuppressive Drug
100%
Immunocompetent Cell
50%
T Cell
50%
Immunotherapy
50%
Programmed Death-Ligand 1
33%
Immune Response
16%
Immune Tolerance
16%
Adaptive Immune System
16%
Vaccination Policy
16%
Cytotoxic T Cell
16%
Monoclonal Antibody
16%
Immune Evasion
16%
Immune Escape
16%
Tumor Escape
16%
Programmed Death 1 Ligand 1
16%